[Dynamics of inflammatory periodontal diseases under the influence of gastroesophageal reflux disease therapy].
Was made a comparative evaluation of the influence of treatment of gastroesophageal reflux disease (GERD) on the course of inflammatory periodontal diseases in patients with combined pathology of periodontal and GERD. Was performed an assessment of GERD symptom severity, the establishment of periodontal status of patients and analysis of the effects of GERD therapy on the course parodontopaty inflammatory genesis (chronic catarrhal gingivitis and chronic periodontitis mild). In patients with inflammatory periodontal diseases, coupled with GERD, was marked by a more pronounced therapeutic effect of combined treatment in comparison with isolated local treatment CDW (HKG and HGPI), which was reflected in the improvement of the parameters of the microcirculation system of periodontal tissues. This suggests the presence of pathogenic link between chronic inflammatory periodontal diseases (CDW) and the presence of pathological gastroesophageal reflux.
T D
TD
Dzhamaldinova
D000328:Adult; D000464:Alginates / Q000627:therapeutic use*; D002908:Chronic Disease; D055113:Chronic Periodontitis / Q000150:complications / Q000473:pathology*; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D005764:Gastroesophageal Reflux / Q000150:complications / Q000188:drug therapy*; D005881:Gingiva / Q000098:blood supply; D005891:Gingivitis / Q000150:complications / Q000473:pathology*; D006801:Humans; D008297:Male; D008833:Microcirculation; D008875:Middle Aged; D009853:Omeprazole / Q000627:therapeutic use*; D010519:Periodontium / Q000098:blood supply; D016896:Treatment Outcome; D055815:Young Adult
D000464:Alginates; D004791:Enzyme Inhibitors; D009853:Omeprazole